British Journal of Anaesthesia, Vol 75, Issue 3 352-354, Copyright © 1995 by The Board of Management and Trustees of the British Journal of Anaesthesia
P. N. Bromley, S. J. Cottam, I. Hilmi, K. C. Tan, N. Heaton, R. Ginsburg and D. R. Potter
N-acetylcysteine (NAC) is an antioxidant agent which has been shown to
benefit patients with fulminant hepatic failure. We have examined its
effect in patients with chronic liver disease undergoing orthotopic liver
transplantation by giving NAC during operation. In a prospective,
randomized, double-blind, placebo-controlled study of 50 patients, NAC
appeared to induce mild vasodilatation, improve oxygen delivery and
consumption, and reduce base deficit, but data interpretation was
difficult. There were no significant effects on mortality, morbidity or
postoperative graft function.
SHORT COMMUNICATION
Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation
Department of Anaesthesia for Liver Transplantation, King's College Hospital, London SE5 9RS; Department of Surgery for Liver Transplantation King's College Hospital, London SE5 9RS
![]()
CiteULike
Connotea
Del.icio.us What's this?